Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.45 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.45 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | PYGB | P11216 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | OGA | O60502 | 4/20 | 0.41 |
| ▸ | HEXA | P06865 | 1/20 | 0.38 |
| ▸ | HEXB | P07686 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL388109 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL757840 | 0.98 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL3290529 | 0.98 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL26987277 | 0.98 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL3292990 | 0.98 | LGALS1 (0.48) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL23848867 | 0.87 | PYGB (0.44) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL9621629 | 0.86 | OGA (0.42) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL23848979 | 0.86 | PYGB (0.39) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL17081176 | 0.86 | PYGB (0.39) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL23848959 | 0.86 | PYGB (0.39) | LGALS1LGALS3LGALS9LGALS8PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9663548-B2 | 10-α/β-D-arabinofuranosyl-undecenes as potential anti-mycobacterial agents and process for the preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-05-30 | — | — | US | disclosed |
| US-20150259372-A1 | 10-a/BETA-D-ARABINOFURANOSYL-UNDECENES AS POTENTIAL ANTI-MYCOBACTERIAL AGENTS AND PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259372-A1 | 10-a/BETA-D-ARABINOFURANOSYL-UNDECENES AS POTENTIAL ANTI-MYCOBACTERIAL AGENTS AND PROCESS FOR THE PREPARATION THEREOF | DCXR, DHPS, MANBA | LGALS1 868/4885LGALS3 1979/4885LGALS9 663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.